Skip to content

A clinical study of drug Eranda for the treatment in patients of Aamvata and Vatarakta

A comparative pharmaco- clinical study of eranda mool(Ricinus communis Linn.) in the management of Aamvata and Vatarakta

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043885
Enrollment
60
Registered
2022-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M241- Other articular cartilage disorders

Interventions

None listed

Sponsors

Government Ayurvedic College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with written consent, 2.Having clinical features of Amavata or Vatarakta, 3.Patients fulfilling subjective and objective criteria like sandhi shool, shotha, sandhi stabhdhata etc. in amavata and Sandhi graha, twaka vaivrnaya, raga etc. in vatarakta

Exclusion criteria

Exclusion criteria: 1.Patients below 30 and above 70 years of age 2. Pregnant and lactating mothers 3. Patients with serious systemic illness 4. Patients with complications of Amavata and Vatarakta

Design outcomes

Primary

MeasureTime frame
Subjective Parameter- Grading will be done with signs and symptoms of both Amavata and Vatarakta respectively. RA Factor, CRP, ESR for Amavata and Uric Acid levels for VataraktaTimepoint: After one month intervention of Erandamool kwatha orally and 15 days after stopping of medicine

Secondary

MeasureTime frame
Subjective Parameter- Grading will be done with signs and symptoms of both Amavata and Vatarakta respectively. RA Factor, CRP, ESR for Amavata and Uric Acid levels for Vatarakta.Timepoint: After one month intervention of erandamool Kwatha orally, and 15 days after stopping of medicine.

Countries

India

Contacts

Public ContactDr Rosy Gupta

Post graduate training and research institute Government Ayurvedic College, Patiala

rrgu04@gmail.com9815818190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026